Orrico-Sánchez, A.
López-Lacort, M.
Muñoz-Quiles, C.
Sanfélix-Gimeno, G.
Díez-Domingo, J.
Funding for this research was provided by:
Janssen Pharmaceuticals (NA)
Article History
Received: 8 January 2019
Accepted: 9 March 2020
First Online: 5 April 2020
Ethics approval and consent to participate
: The Ethics Research Committee of the Dirección General de Salud Pública/Centro Superior de Investigación en Salud Pública approved the study. Additionally, being that it is a retrospective study with 8 years of study period (2008–2015), it would have been not possible to get individual informed consent from the whole population studied (almost 4 million inhabitants). Based on Helsinki’s Declaration (principle 32) and the Law of Biomedical Reseach in Spain (Art. 58.2), the Ethics Committee accepted the exemption.
: Not applicable
: FISABIO has received research grants from various pharmaceutical companies. AOS, MLL, CMQ and JDD ever received travel grants to attend meetings sponsored by pharmaceutical companies. AOS, MLL, CMQ and JDD have been principal investigators in projects sponsored by pharmaceutical companies. JDD acted as Advisor for GSK and SPMSD.